1. Market Research
  2. > Healthcare
  3. > Medical Device
  4. > In Vitro Diagnostics Market Trends

Analysis of the US Immunochemistry Market

  • October 2014
  • 88 pages
  • Frost & Sullivan
Report ID: 2436656

Summary

Table of Contents

Clinicians Will Likely Opt for Integrated Analyzers over Standalone Clinical and Immunoassay Analyzers in the Next 2 Years

This study provides trends in the US immunochemistry market and the clinical chemistry market. The install base of analyzer models from top vendors are projected from 2012 and 2013, and resulting trends have been studied. The study includes list prices of analyzers, analytes detected, and average discounts offered. Customer segmentation includes various analyzers from vendors such as Abbott Diagnostics, Siemens Healthcare, Roche Diagnostics, Phadia (Thermo Fisher Scientific), Alere, Inova Diagnostics, Tosoh Bioscience, bioMérieux, DiaSorin, Bio-Rad, IDS, Ortho-Clinical Diagnostics, Awareness Technology, The Binding Site, and Beckman Coulter.

Executive Summary—Key Findings
-The US immunochemistry market generated $ million in 2013 and is expected to grow at a compound annual growth rate (CAGR) of% from 2013 to 2015. The market comprises the sales of analyzers and reagents. The US immunochemistry market represents % of the US in vitro diagnostics (IVD) market.
-The immunochemistry market is heavily impacted by rapid replacement trends, which affect the clinical chemistry market. The clinical chemistry market contributed % of the US IVD market. The US clinical chemistry market generated $ million in 2013 and is expected to grow at a CAGR of % from 2013 to 2015.
-In terms of technology trends, the market is increasingly seeing the entry of chemiluminescence immunoassay (CLIA) systems, which are replacing older versions. Smaller labs still opt for fluorescent immunoassay (FIA) systems or semi-automated CLIA systems. Enzyme-linked immunosorbent assay (ELISA) systems and open systems are exhibiting some growth because of their open platform capabilities and larger test menu and affordability. FIA and CLIA systems tend to be more expensive. which works in favor of ELISA systems.
-Frost & Sullivan, however, estimates that ELISA systems will eventually experience erosion because of their lack of sensitivity and low specificities, especially as most laboratories are now consolidating and converting to high throughput systems. As a result, many vendors are using this opportunity to offer immunoassay or standalone clinical chemistry systems for a high discounted price. Demand for immunochemistry systems seems to work negatively for vendors. Because of this, the retention of the install base is crucial. Some strategies adopted by vendors include offering large discounts/upgrades, adding automation capabilities to existing modules, and having long reagent rental contracts.
-Frost & Sullivan’s install base analysis reveals that a few open system platforms are declining in their install base, leading to rapid transition to either an FIA or a CLIA system.
-Dominating vendors are Roche Diagnostics, Siemens Healthcare Diagnostics, and Abbott Diagnostics. The US immunochemistry market is seeing the influx of many newer companies from Canada, Japan, China, and Europe. The market has undergone a massive change from a handful of participants offering only ELISA, CLIA, radioimmunoassay (RIA), and FIA as well as multiparametric assays such as microarrays, flow cytometry-based platforms, recombinant immunoassays, and indirect immunofluorescence assays (IFA).

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 60 Million searchable statistics with tables, figures & datasets
  • More than 25,000 trusted sources
  • Single User License — provides access to the report by one individual.
  • Department License — allows you to share the report with up to 5 users
  • Site License — allows the report to be shared amongst all employees in a defined country
  • Corporate License — allows for complete access, globally.

Veronica helps you find the right report:

Testimonials

The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

We were impressed with the support that ReportLinker’s research specialists’ team provided. The report we purchased was useful and provided exactly what we want.

Category Manager at
Ikea

ReportLinker gave access to reliable and useful data while avoiding dispersing resources and spending too much time on unnecessary research.

Executive Director at
PwC Advisory

The customer service was fast, responsive, and 100% professional in all my dealings (...) If we have more research needs, I'll certainly prioritize working with ReportLinker!

Scott Griffith

Vice President Marketing at
Maurice Sporting Goods

The research specialist provided prompt, helpful instructions for accessing ReportLinker's product. He also followed up to make sure everything went smoothly and to ensure an easy transition to the next stage of my research

Jessica P Huffman

Research Associate at
American Transportation Research Institute

Excellent customer service. Very responsive and fast.

Director, Corporate Strategy at
Ingredion

I reached out to ReportLinker for a detailed market study on the Air Treatment industry. The quality of the report, the research specialist’s willingness to solve my queries exceeded my expectations. I would definitely recommend ReportLinker for in-depth industry information.

Mariana Mendoza

Global Platform Senior Manager at
Whirlpool Corporation

Thanks! I like what you've provided and will certainly come back if I need to do further research works.

Bee Hin Png

CEO at
LDR Pte Ltd

The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

Purchase Reports From Reputable Market Research Publishers

Hematology and Flow Cytometry Analyzers and Reagents Market 2021: A 74-Country Analysis--Supplier Shares and Strategies, Test Volume and Sales Segment Forecasts, Technology and Instrumentation Review

  • $ 47500
  • Industry report
  • May 2017
  • by Venture Planning Group

This 74-country survey from VPGMarketResearch.com provides granular data and analysis not available elsewhere. The survey is designed to help current suppliers and potential market entrants identify and ...

Coagulation Testing Analyzers and Reagents Market 2021: A 74-Country Analysis--Supplier Shares and Strategies, Volume and Sales Segment Forecasts, Technology and Instrumentation Review

  • $ 33500
  • Industry report
  • May 2017
  • by Venture Planning Group

This new 74-country survey from VPGMarketResearch.com provides granular data and analysis not available from any other source. The report explores business and technological trends; provides test volume ...

2017 Europe Hematology and Flow Cytometry Market: Sales and Volume Forecasts for 40 Tests, Supplier Shares, Competitive Strategies, Instrumentation Review, Emerging Technologies

  • $ 29500
  • Industry report
  • February 2017
  • by Venture Planning Group

This new 31-country report from VPGMarketResearch.com is available by country, market segment, section, or individual test. The survey is designed to help current suppliers and potential market entrants ...


ref:plp2014

Reportlinker.com © Copyright 2017. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.